Tudor Investment Corp
PLRX icon

Tudor Investment Corp’s Pliant Therapeutics PLRX Stock Holding History

Tudor Investment Corp’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.9K Hold
29,729
– – ﹤0.01% 3440
2026
Q1 		$37.5K Hold
29,729
– – ﹤0.01% 3496
2025
Q4 		$36.3K Hold
29,729
– – ﹤0.01% 3404
2025
Q3 		$44K Hold
29,729
– – ﹤0.01% 3280
2025
Q2 		$34.5K Sell
29,729
-203
-0.7% -$287 ﹤0.01% 3170
2025
Q1 		$40.4K Buy
+29,932
New +$182K ﹤0.01% 2964
2024
Q4 		– Sell
-22,628
Closed -$254K – 3402
2024
Q3 		$254K Sell
22,628
-9,618
-30% -$120K ﹤0.01% 2406
2024
Q2 		$347K Buy
32,246
+5,349
+20% +$69K ﹤0.01% 1961
2024
Q1 		$401K Buy
+26,897
New +$444K ﹤0.01% 1746
2023
Q3 		– Sell
-27,725
Closed -$502K – 2739
2023
Q2 		$502K Sell
27,725
-18,482
-40% -$438K 0.01% 1711
2023
Q1 		$1.23M Buy
46,207
+22,078
+91% +$629K 0.02% 1069
2022
Q4 		$466K Buy
24,129
+153
+0.6% +$3.2K 0.01% 1627
2022
Q3 		$501K Buy
+23,976
New +$459K 0.01% 1393

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Tudor Investment Corp's PLRX Position: Q2 2026 in Review

Tudor Investment Corp held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 29,729 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3440.

Tudor Investment Corp first reported a position in PLRX in Q3 2022 and has held it in 13 quarters since. The position peaked at $1.23M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Tudor Investment Corp held 29,729 shares of Pliant Therapeutics worth $33.9K as of Q2 2026.
  • Tudor Investment Corp left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up ﹤0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #3440 holding.
  • Tudor Investment Corp first reported a position in Pliant Therapeutics in Q3 2022 and has held it in 13 quarters since.
  • Tudor Investment Corp's Pliant Therapeutics position peaked at $1.23M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.